Savarese, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 1.274
AS - Asia 1.154
EU - Europa 456
SA - Sud America 266
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 27
Totale 3.214
Nazione #
US - Stati Uniti d'America 1.205
SG - Singapore 430
CN - Cina 252
BR - Brasile 227
IT - Italia 182
HK - Hong Kong 163
BD - Bangladesh 102
VN - Vietnam 73
DE - Germania 48
FR - Francia 42
CA - Canada 38
RU - Federazione Russa 37
GB - Regno Unito 34
TR - Turchia 34
FI - Finlandia 27
IN - India 23
NL - Olanda 16
IQ - Iraq 15
AT - Austria 12
ES - Italia 12
SA - Arabia Saudita 12
AR - Argentina 11
UA - Ucraina 11
CO - Colombia 8
MX - Messico 8
PK - Pakistan 8
PL - Polonia 8
JP - Giappone 7
CR - Costa Rica 6
MA - Marocco 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
SE - Svezia 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
PH - Filippine 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
ID - Indonesia 3
NP - Nepal 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
HT - Haiti 2
HU - Ungheria 2
IE - Irlanda 2
IR - Iran 2
MD - Moldavia 2
MG - Madagascar 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GT - Guatemala 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TC - Turks e Caicos 1
TH - Thailandia 1
Totale 3.177
Città #
Singapore 220
Hong Kong 162
Ashburn 145
San Jose 107
Beijing 76
The Dalles 68
Council Bluffs 62
New York 62
Dallas 60
Los Angeles 55
Santa Clara 34
Columbus 31
Lauterbourg 30
Istanbul 28
Milan 27
San Francisco 26
São Paulo 26
Ho Chi Minh City 25
Orem 21
Buffalo 17
Moscow 17
Romola 17
Atlanta 16
Hanoi 16
Munich 15
Rome 15
Lappeenranta 14
Montreal 14
Phoenix 14
Chicago 13
Redondo Beach 13
Shanghai 13
Denver 11
Frankfurt am Main 11
Nuremberg 11
Boston 10
Brooklyn 10
Chennai 10
Turin 10
Toronto 9
Brasília 8
Seattle 8
Da Nang 7
Guangzhou 7
Naples 7
Rio de Janeiro 7
Warsaw 7
Amsterdam 6
Baghdad 6
Bari 6
Belo Horizonte 6
Charlotte 6
Helsinki 6
San José 6
Tokyo 6
Turku 6
Hangzhou 5
London 5
Pittsburgh 5
Stockholm 5
Vienna 5
Boardman 4
Brescia 4
Dhaka 4
Erbil 4
Jeddah 4
Las Vegas 4
Manchester 4
Nairobi 4
San Rafael 4
São Bernardo do Campo 4
West Jordan 4
Airola 3
Baltimore 3
Basra 3
Cagliari 3
Caracas 3
Catania 3
Contagem 3
Figino 3
Goiânia 3
Haiphong 3
Houston 3
Itajaí 3
Johannesburg 3
Kyiv 3
Lahore 3
Livorno 3
Macapá 3
Manaus 3
Medellín 3
Medina 3
Miami 3
Montevideo 3
New Orleans 3
Piracicaba 3
Porto Alegre 3
Potsdam 3
Salvador 3
Serra 3
Totale 1.799
Nome #
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 277
2024 update in heart failure 191
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC 139
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC 127
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) 112
Insights into the European heart failure epidemiology 99
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 93
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 92
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 90
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC 86
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry 86
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 85
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 84
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 83
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 80
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry 80
Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis 80
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 79
Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction 79
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 78
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: an analysis from the Swedish Heart Failure Registry 77
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 75
Comprehensive Characterization of Non-Cardiac Comorbidities in Acute Heart Failure- an analysis of ESC-HFA EORP Heart Failure Long-Term Registry 74
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 74
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC 72
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure 69
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 67
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 65
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) 64
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis 62
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 61
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: insight from the ESC-HFA EORP Heart Failure Long-Term Registry 59
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure 58
Rationale and Design of the ESC Heart Failure III Registry - Implementation and Discovery 57
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions 56
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC 55
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice 49
Totale 3.214
Categoria #
all - tutte 15.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 0 5
2023/2024195 3 8 4 7 16 2 11 8 46 10 38 42
2024/2025590 9 2 25 70 49 37 79 15 52 40 114 98
2025/20261.807 215 197 117 203 139 98 207 141 173 121 123 73
2026/2027617 90 166 291 70 0 0 0 0 0 0 0 0
Totale 3.214